EMPA-KIDNEY baseline infographic

Related Articles

EMPA-KIDNEY study results video | Prof William Herrington

EMPA-KIDNEY full study publication

EMPA-KIDNEY baseline publication

EMPA-KIDNEY study results infographic

For healthcare professionals only. This page is for educational purposes only with the intent to communicate the EMPA-KIDNEY trial results. Empagliflozin is not indicated for the treatment of patients with chronic kidney disease in the Philippines. Please refer to the local approved product information for the current indication. Date: February 2023 RIN No. SC-PH-04498
SC-PH-04471
%product_id%